Overview
Greg Mitchell is a seasoned intellectual property advisor with a particular focus in the life sciences, biopharmaceutical and clean tech sectors. With extensive experience in developing and implementing global patent strategies, he provides comprehensive IP counseling across diverse technologies. Greg has developed and implemented IP strategies for numerous IP-value driven companies, many of which have subsequently had M&A or licensing deals worth hundreds of millions or billions of dollars.
Greg’s strong technical background and practical business acumen facilitate timely and strategic advice that is always focused on advancing clients' business goals. Clients look to his experience and in-depth knowledge of science, patent strategy, due diligence and corporate transactions — skillsets that allow the agile navigation of the biopharmaceutical sector’s complexities, empowering informed decisions while mitigating legal risks.
Life Sciences & Biotechnology
Greg provides patent and transactional counseling for a broad range of life sciences technologies, including small molecule pharmaceuticals, mRNA and gene therapies, gene editing (CRISPR), protein and cell therapies, pharmaceutical formulations, synthetic biology, biomaterials, and food technologies. He works closely with clients to navigate complex IP due diligence processes, particularly in financing activities such as venture capital (seed, early and late-stage), public offerings, and partnerships, including collaborations with universities, clinical research organizations (CROs), contract development and manufacturing organizations (CDMOs), and commercial licensing agreements with pharmaceutical and biotechnology companies.
Counseling
Greg's experience includes developing and implementing IP strategies, patent prosecution, IP due diligence (both buy- and sell-side), and IP risk assessment for venture financings, public offerings, and mergers and acquisitions. He has led numerous IP due diligence efforts and negotiations for both investors and companies involved in financings and acquisitions. Greg has represented venture capital firms and life sciences companies, positioning him as a go-to resource for IP-driven work.
Clean Technology
Greg also provides IP counseling for a broad range of clean technologies, including green and renewable materials, such as energy production and storage materials, biomaterials and metals.
Prior Experience
Before joining Faegre Drinker, Greg practiced in the intellectual property and life sciences practices at another international law firm. His private sector experience includes working as a VP of intellectual property for a material sciences company, which developed lithium-ion battery nanomaterials. He also worked as a bench chemist at a leading nucleotide and oligonucleotide manufacturing company.
Greg also worked as a patent examiner in the U.S. Patent and Trademark Office and has been a registered patent agent since 2003.
Related Legal Services
Related Industries
Credentials
Bar Admissions
California
New York
Tennessee
Texas
U.S. Patent and Trademark Office
Education
George Washington University Law School
J.D. with honors, Order of the Coif (2007)
University of California, Los Angeles (UCLA)
Ph.D. in Chemistry (2003)
University of California, Los Angeles (UCLA)
M.S. in Chemistry (2001)
University of San Diego
B.A. in Chemistry (1998)